Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 11/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
| ▸ | CCR3 | P51677 | 1/20 | 0.40 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | RORC | P51449 | 1/20 | 0.38 |
| ▸ | RBP4 | P02753 | 1/20 | 0.38 |
| ▸ | ULK1 | O75385 | 1/20 | 0.38 |
| ▸ | ULK2 | Q8IYT8 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | ECE2 | P0DPD6 | 1/20 | 0.37 |
| ▸ | MLNR | O43193 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22588162 | 0.87 | HDAC3 (0.45) | SYKTRPV1CCR3RBP4ULK1 | |
| SCHEMBL31285878 | 0.84 | MAPK1 (0.48) | SYKTRPV1CCR3ECE2 | |
| SCHEMBL22587986 | 0.84 | MAPK1 (0.48) | SYKTRPV1CCR3ECE2 | |
| SCHEMBL22587961 | 0.76 | MAPK1 (0.41) | TRPV1ENPP2RBP4POLB | |
| SCHEMBL29619918 | 0.74 | CCR3 (0.44) | TRPV1CCR3RORCRBP4POLB | |
| SCHEMBL30317255 | 0.74 | CCR3 (0.44) | TRPV1CCR3RORCRBP4POLB | |
| SCHEMBL22587689 | 0.74 | MLNR (0.48) | ENPP2POLBMLNR | |
| SCHEMBL31285920 | 0.74 | MLNR (0.48) | ENPP2POLBMLNR | |
| SCHEMBL31285877 | 0.74 | CCR3 (0.43) | TRPV1CCR3RORCRBP4POLB | |
| SCHEMBL22605545 | 0.74 | CCR3 (0.43) | TRPV1CCR3RORCRBP4POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111848598-A | Heterocyclic ring-containing compound, application thereof and composition containing heterocyclic ring-containing compound | 健艾仕生物医药有限公司 | 2020-10-30 | — | — | CN | disclosed |